
After around two years on the board of directors at Swedish biotech firm Vicore Pharma, Michael Wolff Jensen has decided to step down from his chair position, the company has announced in a press release.
According to the statement, Wolff Jensen’s resignation from the board, where he has served since 2020, is ”due to personal reasons.”
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app